Greg Hurlbut

Founder at SIONNA THERAPEUTICS, INC.

Consumer Services

Health Technology

Profile

Greg Hurlbut is the founder of Sionna Therapeutics, Inc. since 2019, holding the title of Senior Vice President-Discovery Research.
Former job includes Head-Protein Conformational Diseases at Genzyme Therapeutics Ltd. Education includes an undergraduate degree from the University of Massachusetts and a doctorate from Université Paris-Saclay.

Greg Hurlbut active positions

Companies	Position	Start
SIONNA THERAPEUTICS, INC.	Founder	01/08/2019

All active positions of Greg Hurlbut

Former positions of Greg Hurlbut

Companies	Position	End
Genzyme Therapeutics Ltd. Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases	Corporate Officer/Principal	-

See the detail of Greg Hurlbut's experience

Training of Greg Hurlbut

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Greg Hurlbut's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Massachusetts University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Genzyme Therapeutics Ltd. Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases	Health Technology
Université Paris-Saclay Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases	Health Technology